Where it comes from
- Made in
- Read off the mitochondrial sequence in 2016, then found by antibody in mouse liver and kidney
- Sent out by
- Unknown; no study has reported it in blood
- Acts on
- Cells, including cancer cells
What it does
- Promotes apoptosis: in both cell lines tested it increased cell death, the opposite of SHLP2 and SHLP3 from the same stretch of the same gene 1
- The shortest of the six at 20 residues, and the only one whose effect runs against humanin’s 1
- Nothing explains the reversal. None of the six has a known receptor, so there is the observation and no mechanism 2
In medicine
- None. No blood measurement in people has been reported and no disease has been linked to it
- One of the two cell lines in which it killed cells was a prostate cancer line, and that single result is the whole basis for calling it cancer-relevant 1
Beyond the body’s own use
- Nothing is in trials. SHLP6 has not been given to an animal, so the apoptosis it causes has only ever been seen in a dish 1
- Whether an apoptosis-promoting peptide in the mitochondrial genome makes sense beside five siblings and humanin that keep cells alive is open: one paper found the effect in 2016 and nobody has repeated it 2
Sources
This card describes what a medicine is for and what the evidence says; it recommends nothing. Talk to your clinician about anything you read here.